Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab for Carotid Plaque Stabilization and Regression
NCT04730973Phase 4Unknown
- Sponsor
- Azienda Ospedaliera Ordine Mauriziano di Torino
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in carotid artery disease, sponsored by Azienda Ospedaliera Ordine Mauriziano di Torino. Status: unknown.
02
Drugs
evolocumab
03
Conditions
carotid artery disease
Beyond the preview
Go deeper on NCT04730973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04730973.